Myelodysplastic Syndromes, Version 2.2015: Featured Updates to the NCCN Guidelines

The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a highly variable disease course that depends largely on risk factors. Risk evaluation is therefore a critical component of decision-making in the treatment of MDS. The development of new...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Natl Compr Canc Netw
Asıl Yazarlar: Greenberg, Peter L., Stone, Richard M., Bejar, Rafael, Bennett, John M., Bloomfield, Clara D., Borate, Uma, De Castro, Carlos M., Deeg, H. Joachim, DeZern, Amy E., Fathi, Amir T., Frankfurt, Olga, Gaensler, Karin, Garcia-Manero, Guillermo, Griffiths, Elizabeth A., Head, David, Klimek, Virginia, Komrokji, Rami, Kujawski, Lisa A., Maness, Lori J., O’Donnell, Margaret R., Pollyea, Daniel A., Scott, Bart, Shami, Paul J., Stein, Brady L., Westervelt, Peter, Wheeler, Benton, Shead, Dorothy A., Smith, Courtney
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696005/
https://ncbi.nlm.nih.gov/pubmed/25736003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller